BRCA1 and ovarian carcinoma: Consequently, mutations in BRCA1/2 genes hinder proper DNA repair and have been shown to increase the malignancy risk for hereditary cancers, especially breast and ovarian cancers (Gudmundsdottir and Ashworth, 2006; Ratner et al., 2019).